Advances in targeted therapy and immunotherapy for esophageal cancer
Abstract. Esophageal cancer (EC) is one of the most common aggressive malignant tumors in the digestive system with a severe epidemiological situation and poor prognosis. The early diagnostic rate of EC is low, and most EC patients are diagnosed at an advanced stage. Multiple multimodality treatment...
Main Authors: | Haiou Yang, Xuewei Li, Wenhui Yang, Xiangxiang Pan, Peifang Wei |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2023-08-01
|
Series: | Chinese Medical Journal |
Online Access: | http://journals.lww.com/10.1097/CM9.0000000000002768 |
Similar Items
-
Research progress in targeted therapy and immunotherapy for gastric cancer
by: Xuewei Li, et al.
Published: (2022-06-01) -
Treatments for resectable esophageal cancer: from traditional systemic therapy to immunotherapy
by: Yan Yan, et al.
Published: (2022-09-01) -
Targeted Therapies and Immunotherapies in the Treatment of Esophageal Cancers
by: Adam Barsouk, et al.
Published: (2019-09-01) -
Dawn of Advanced Thyroid Cancer Therapy: Targeted Therapy and Immunotherapy
by: LIU Shanting, et al.
Published: (2023-01-01) -
Novel targeted therapies and immunotherapy for advanced thyroid cancers
by: George E. Naoum, et al.
Published: (2018-02-01)